Toward an even more impressive and productive future

Kaneka Pharma Europe NV focuses on lipoprotein apheresis in the European market. Furthermore, interventional products and cell processing devices are part of its main business.

Kaneka Corporation is the parent company of Kaneka Pharma Europe NV. Kaneka is well known for the innovative technologies applied in its medical devices and for building blocks for active pharmaceutical ingredients, macromolecules, fermentation, and bioscience. Kaneka is touching the lives of people all over the world with a nearly infinite number of possibilities enabled by going beyond the boundary of traditional chemistry.